Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Global Blood Ther
(NQ:
GBT
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Oct 4, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Global Blood Ther
< Previous
1
2
3
4
Next >
The Daily Biotech Pulse: J&J, Novartis Report Solid Results, Chembio Soars On COVID Test Order, Lumos Signals Clinical Trial Delay
July 21, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 20) Alnylam Pharmaceuticals,...
Via
Benzinga
Global Blood Therapeutics: Return On Capital Employed Insights
July 01, 2021
During Q1, Global Blood Therapeutics's (NASDAQ:GBT) reported sales totaled $39.04 million. Despite a 20.83% in earnings, the company posted a loss of $71.03 million. Global Blood...
Via
Benzinga
Why Global Blood Therapeutics Moved Higher Wednesday
July 01, 2021
The pharmaceutical company, which specializes in therapies to fight sickle cell disease, rose nearly 8% on Wednesday.
Via
The Motley Fool
Earnings Scheduled For May 5, 2021
May 05, 2021
Companies Reporting Before The Bell • Monmouth Real Estate (NYSE:MNR) is likely to report earnings for its second quarter. • EyePoint Pharmaceuticals (NASDAQ:EYPT...
Via
Benzinga
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge
May 01, 2021
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name...
Via
Benzinga
Exposures
Product Safety
The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street
July 20, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 19) Cytokinetics, Incorporated...
Via
Benzinga
The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study
July 16, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 15) IVERIC bio, Inc. (NASDAQ:...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
The Daily Biotech Pulse: Spero Spikes On Pfizer Investment, FDA Nod For Jazz, Orchard Signs Licensing Deal, Acumen Pharma Debuts
July 01, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 30) Ambrx Biopharma Inc. (NYSE...
Via
Benzinga
Exposures
Product Safety
Stocks That Hit 52-Week Lows On Wednesday
June 30, 2021
During Wednesday's morning session, 29 stocks hit new 52-week lows. Points of Interest: The largest company by market cap to set a new 52-week low was CoStar Gr (...
Via
Benzinga
Looking Into Global Blood Therapeutics's Return On Capital Employed
June 30, 2021
In Q1, Global Blood Therapeutics (NASDAQ:GBT) posted sales of $39.04 million. Earnings were up 20.83%, but Global Blood Therapeutics still reported an overall loss of $71.03...
Via
Benzinga
The Daily Biotech Pulse: COVID Disappointments For Altimmune And Angion, Brickell Jumps On Hyperhidrosis Study Updates, 2 IPOs
June 30, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 29) 10x Genomics, Inc. (NASDAQ...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
June 28, 2021
Gainers Intellia Therapeutics (NASDAQ:NTLA
Via
Benzinga
The Daily Biotech Pulse: Sanofi Bets Big On mRNA Tech, Decision Day For MediWound, DiaMedica Issues Kidney Disease Data Readout
June 29, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 28) Alexion Pharmaceuticals,...
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
June 28, 2021
Before 10 a.m. ET on Monday, 7 stocks hit new 52-week lows. Noteworthy Mentions: The largest company in terms of market cap to set a new 52-week low was CoStar Gr (...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 28, 2021
June 28, 2021
Upgrades For Toll Brothers Inc (NYSE:
Via
Benzinga
14 Biotech Stocks To Watch Over The Next 6 Months
June 23, 2021
Biotechs are at the mercy of several make-or-break catalysts that invariably have a big impact on stocks. A case in point was the strong upside in Biogen Inc.'s (NASDAQ:...
Via
Benzinga
The Week Ahead In Biotech: Biogen, Alexion And Vertex FDA Decisions, Multiple Conference Presentations On The Deck
June 07, 2021
Biopharma stocks advanced in the truncated week ended June 4 amid the broader market strength. The American Society for Clinical Oncology meeting got underway during the week,...
Via
Benzinga
Exposures
Product Safety
Vaccine Stocks Call For Billions In Sales Even As Covid Resisters Dig In: IBD/TIPP Poll
June 04, 2021
The number of people resistant to receiving a Covid vaccine didn't budget in May, according to the IBD/TIPP Poll. But vaccine stocks aren't sweating it, experts say.
Via
Investor's Business Daily
Global Blood Therapeutics Q1 Earnings Miss Estimates On Disappointing Sales For Its Sickle-Cell Disease Drug
May 06, 2021
Global Blood Therapeutics Inc (NASDAQ: GBT) reported a Q1 EPS loss of ($1.21) wider than the anticipated loss estimate of $1.01. Q1 sales of $39.04 million...
Via
Benzinga
Topics
Earnings
Exposures
Financial
Why Global Blood Therapeutics Stock Is Sinking Today
May 06, 2021
The company reported disappointing sales for its sickle-cell disease drug.
Via
The Motley Fool
Global Blood Therapeutics (GBT) Q1 2021 Earnings Call Transcript
May 06, 2021
GBT earnings call for the period ending March 31, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
A Peek Into The Markets: US Stock Futures Edge Higher; Bank Earnings In Focus
April 14, 2021
Pre-open movers U.S. stock futures traded slightly higher in early pre-market trade after the Nasdaq jumped over 1% in the previous session. Investors are awaiting earnings...
Via
Benzinga
The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts
May 14, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 13) Alexion Pharmaceuticals, Inc...
Via
Benzinga
Exposures
Product Safety
The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs
May 07, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 6) GT Biopharma, Inc. (NASDAQ:...
Via
Benzinga
The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues
May 05, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 4) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 14, 2021
April 14, 2021
Upgrades For Cardlytics Inc (NASDAQ:CDLX), Craig-Hallum upgraded the previous rating of Hold to Buy. For the fourth quarter, Cardlytics had an EPS of $0.05, compared to...
Via
Benzinga
Global Blood Therapeutics' Sickle Cell Med Results In Rapid, Durable Improvements In Hemoglobin Levels Throughout 72 Weeks Of Treatment
April 08, 2021
Global Blood Therapeutics Inc (NASDAQ: GBT) has announced The Lancet Haematology has published the complete analysis of 72-week data from the Phase 3 HOPE...
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.